Structure-based drug design for new therapies for Leishmaniasis and Chagas disease (2025)
Pohl, Ehmke 
; Silber, Ariel Mariano ; Pohl, Stefanie Freitag ; Sowerby, Kate
Source: Acta Crystallographica. Section A: Foundations and Advances. Conference titles: European Crystallography Meeting. Unidade: ICB
Subjects: PARASITOLOGIA, PROTOZOA, ANTIPARASITÁRIOS, LEISHMANIA, AMINOÁCIDOS, DOENÇA DE CHAGAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
POHL, Ehmke et al. Structure-based drug design for new therapies for Leishmaniasis and Chagas disease. Acta Crystallographica. Section A: Foundations and Advances. Hoboken: Instituto de Ciências Biomédicas, Universidade de São Paulo. Disponível em: https://doi.org/10.1107/S2053273324099194. Acesso em: 16 fev. 2026. , 2025APA
Pohl, E., Silber, A. M., Pohl, S. F., & Sowerby, K. (2025). Structure-based drug design for new therapies for Leishmaniasis and Chagas disease. Acta Crystallographica. Section A: Foundations and Advances. Hoboken: Instituto de Ciências Biomédicas, Universidade de São Paulo. doi:10.1107/S2053273324099194NLM
Pohl E, Silber AM, Pohl SF, Sowerby K. Structure-based drug design for new therapies for Leishmaniasis and Chagas disease [Internet]. Acta Crystallographica. Section A: Foundations and Advances. 2025 ; 80[citado 2026 fev. 16 ] Available from: https://doi.org/10.1107/S2053273324099194Vancouver
Pohl E, Silber AM, Pohl SF, Sowerby K. Structure-based drug design for new therapies for Leishmaniasis and Chagas disease [Internet]. Acta Crystallographica. Section A: Foundations and Advances. 2025 ; 80[citado 2026 fev. 16 ] Available from: https://doi.org/10.1107/S2053273324099194
